FACTORS FOR LIFE

Serial Number 88871026
606

Registration Progress

Application Filed
Apr 14, 2020
Under Examination
Jul 20, 2021
Approved for Publication
May 25, 2021
Published for Opposition
May 25, 2021
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: FACTORS FOR LIFE
Previous Owner: CSL Behring GmbH
Classes: 035, 042, 044

Trademark Image

FACTORS FOR LIFE

Basic Information

Serial Number
88871026
Filing Date
April 14, 2020
Published for Opposition
May 25, 2021
Abandonment Date
August 26, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 26, 2024
Classes
035 042 044

Rights Holder

CSL Behring GmbH

16
Address
Emil-von Behring-Strasse 76
Marburg 35041
DE

Ownership History

CSL Behring GmbH

Original Applicant
16
Marburg DE

CSL Behring GmbH

Owner at Publication
16
Marburg DE

Legal Representation

Attorney
Scott D. Woldow

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

38 events
Date Code Type Description Documents
Aug 26, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 26, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Jan 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 10, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Dec 19, 2023 EXT5 S SOU EXTENSION 5 FILED Loading...
Jan 10, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 19, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 15, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 13, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 13, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jul 13, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 22, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 20, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 20, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 20, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 21, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 21, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 13, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 13, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 20, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 25, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 25, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 5, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 22, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 22, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 22, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Apr 15, 2021 ALIE A ASSIGNED TO LIE Loading...
Jan 12, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 13, 2020 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...
Jul 13, 2020 GPRA F PRIORITY ACTION E-MAILED Loading...
Jul 13, 2020 CPRA R PRIORITY ACTION WRITTEN Loading...
Jul 2, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 22, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 17, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Promoting public awareness of blood conditions, diseases, disorders, and treatment; promoting the interests of patients with blood disorders by means of public advocacy, including through social media and events organized by others; promoting public awareness of the need for influenza immunization and vaccination programs; public policy research services concerning policy initiatives for blood conditions and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting the donation of blood and plasma by means of arranging and conducting incentive reward programs
Class 042
Scientific research and development services
Class 044
Providing medical information concerning blood products for humans, especially blood proteins for therapeutic use, blood clotting agents and antihemophilic factors, fibrinogen concentrate, and pharmaceutical preparations for the treatment of blood or bleeding disorders and deficiencies of blood coagulation; providing medical information and treatment information in the field of health; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matter

Classification

International Classes
035 042 044